Understanding how certain immune cells help reduce allergic lung inflammation
Mechanism of CX3CR1+ macrophage-mediated resolution of eosinophilic allergic lung inflammation
This study is looking at how a special type of immune cell helps calm down allergic reactions in the lungs, which could lead to better treatments for asthma and similar conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11030758 on NIH RePORTER |
What this research studies
This research investigates the role of a specific type of immune cell, known as CX3CR1+ macrophages, in resolving allergic inflammation in the lungs. By using advanced techniques like mass cytometry and single-cell RNA sequencing, the study aims to identify how these macrophages interact with other immune cells, particularly eosinophils, during allergic reactions. The findings could provide insights into the mechanisms that control inflammation in conditions like asthma, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with allergic asthma who experience eosinophilic inflammation in their lungs.
Not a fit: Patients with non-allergic asthma or those without eosinophilic inflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the management of allergic asthma and reduce inflammation in patients.
How similar studies have performed: Previous research has shown promising results in understanding macrophage roles in inflammation, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Park, Gye Young — University of Illinois at Chicago
- Study coordinator: Park, Gye Young
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.